Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate Cancer
Top Cited Papers
- 1 August 2007
- journal article
- research article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 189 (2), 323-328
- https://doi.org/10.2214/ajr.07.2211
Abstract
OBJECTIVE. The objective of our study was to compare T2-weighted MRI alone and T2 combined with diffusion-weighted imaging (DWI) for the localization of prostate cancer. SUBJECTS AND METHODS. T2-weighted imaging and DWI (b value = 600 s/mm2) were performed in 49 patients before radical prostatectomy using an endorectal coil at 1.5 T in this prospective trial. The peripheral zone of the prostate was divided into sextants and the transition zone into left and right halves. T2 images alone and then T2 images combined with apparent diffusion coefficient (ADC) maps (T2 + DWI) were scored for the likelihood of tumor and were compared with whole-mount histology results. Fixed window and level settings were used to display the ADC maps. Only tumors with an area of more than 0.13 cm2 (> 4 mm diameter) and a Gleason score of ≥ 6 were considered significant. The area under the receiver operating characteristic curve (Az) was used to assess accuracy. RESULTS. In the peripheral zone, the Az value was significantly higher (p = 0.004) for T2 plus DWI (Az = 0.89) than for T2 imaging alone (Az = 0.81). Performance was poorer in the transition zone for both T2 plus DWI (Az = 0.78) and T2 (Az = 0.79). For the whole prostate, sensitivity was significantly higher (p < 0.001) with T2 plus DWI (81% [120/149]) than with T2 imaging alone (54% [81/149]), with T2 plus DWI showing only a slight loss in specificity compared with T2 imaging alone (84% [204/243] vs 91% [222/243], respectively). CONCLUSION. Combined T2 and DWI MRI is better than T2 imaging alone in the detection of significant cancer (Gleason score ≥ 6 and diameter > 4 mm) within the peripheral zone of the prostate.Keywords
This publication has 22 references indexed in Scilit:
- Combined diffusion‐weighted and dynamic contrast‐enhanced MRI for prostate cancer diagnosis—Correlation with biopsy and histopathologyJournal of Magnetic Resonance Imaging, 2006
- COMPARISON OF ENDORECTAL MAGNETIC RESONANCE IMAGING, GUIDED PROSTATE BIOPSY AND DIGITAL RECTAL EXAMINATION IN THE PREOPERATIVE ANATOMICAL LOCALIZATION OF PROSTATE CANCERJournal of Urology, 2005
- Endorectal diffusion‐weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissueJournal of Magnetic Resonance Imaging, 2004
- In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imagingJournal of Magnetic Resonance Imaging, 2002
- SEXTANT LOCALIZATION OF PROSTATE CANCER: COMPARISON OF SEXTANT BIOPSY, MAGNETIC RESONANCE IMAGING AND MAGNETIC RESONANCE SPECTROSCOPIC IMAGING WITH STEP SECTION HISTOLOGYJournal of Urology, 2000
- Prostate Cancer: Localization with Three-dimensional Proton MR Spectroscopic Imaging—Clinicopathologic StudyRadiology, 1999
- Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed dataStatistics in Medicine, 1998
- Extension of receiver operating characteristic analysis to data concerning multiple signal detection tasksAcademic Radiology, 1997
- Focal therapy for prostate cancer 1996: Maximizing outcomeUrology, 1997
- Tissue-shrinkage Correction Factor in the Calculation of Prostate Cancer VolumeThe American Journal of Surgical Pathology, 1996